COVID-19 Worsened Substance Use Disparities Among Victimized Adolescents
Adolescents who experienced multiple forms of victimization had 3.5 times higher odds of marijuana use during the pandemic, and the gap between victimized and non-victimized youth widened from 2019 to 2023.
Quick Facts
What This Study Found
Among 52,679 US adolescents from the YRBS (2013-2023), 27.2% reported at least one form of victimization. Those experiencing sexual victimization had higher odds of alcohol (aOR=2.79) and other drug use (aOR=3.65). Youth with multiple victimizations had the highest substance use risk overall, with marijuana use odds peaking at aOR=3.53 during the pandemic. While marijuana use declined broadly in 2021, it rebounded to aOR=1.72 by 2023 specifically among the multiple-victimization group. Victimization-by-year interactions were significant, indicating widening disparities over time.
Key Numbers
52,679 adolescents; 27.2% reported victimization; multiple victimizations: marijuana aOR=3.53 during pandemic; sexual victimization: alcohol aOR=2.79, other drug aOR=3.65; marijuana rebounded to aOR=1.72 in 2023 among multiple-victimization group
How They Did This
Analysis of nationally representative Youth Risk Behavior Survey data (2013-2023, N=52,679). Victimization categorized as school bullying, electronic bullying, sexual victimization, or multiple. Linear logistic regression assessed trends and victimization-by-year interactions. Difference-in-differences regression tested changes across pre-COVID, pandemic, and post-COVID periods.
Why This Research Matters
The pandemic did not affect all adolescents equally. Youth who were already vulnerable through victimization experienced disproportionately worsened substance use outcomes, and these disparities persisted even after pandemic restrictions eased.
The Bigger Picture
Universal prevention programs may not reach the youth at greatest risk. The widening substance use gap between victimized and non-victimized adolescents during and after COVID suggests trauma-informed, targeted approaches are needed alongside broader prevention efforts.
What This Study Doesn't Tell Us
YRBS is school-based and excludes non-enrolled youth, who may have higher victimization and substance use rates. Self-report measures. Cross-sectional at each wave, though difference-in-differences approach strengthens causal inference. Cannot assess dose-response relationships.
Questions This Raises
- ?Are post-pandemic prevention resources reaching multiply-victimized youth?
- ?Would trauma-focused interventions reduce the substance use rebound seen in 2023?
Trust & Context
- Key Stat:
- Evidence Grade:
- Strong: nationally representative data across five survey waves with robust statistical methods including difference-in-differences analysis.
- Study Age:
- 2025 publication using 2013-2023 YRBS data
- Original Title:
- Trends of Adolescent Substance Use by Type of Victimization: COVID-19 Interaction Effects in the United States Youth Risk Behavior Survey (2013-2023).
- Published In:
- Substance use & misuse, 1-11 (2025)
- Authors:
- Gu, Hyejin, Myong, Jun-Pyo
- Database ID:
- RTHC-06596
Evidence Hierarchy
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-06596APA
Gu, Hyejin; Myong, Jun-Pyo. (2025). Trends of Adolescent Substance Use by Type of Victimization: COVID-19 Interaction Effects in the United States Youth Risk Behavior Survey (2013-2023).. Substance use & misuse, 1-11. https://doi.org/10.1080/10826084.2025.2597457
MLA
Gu, Hyejin, et al. "Trends of Adolescent Substance Use by Type of Victimization: COVID-19 Interaction Effects in the United States Youth Risk Behavior Survey (2013-2023).." Substance use & misuse, 2025. https://doi.org/10.1080/10826084.2025.2597457
RethinkTHC
RethinkTHC Research Database. "Trends of Adolescent Substance Use by Type of Victimization:..." RTHC-06596. Retrieved from https://rethinkthc.com/research/gu-2025-trends-of-adolescent-substance
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.